Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.55 USD | +1.71% | +4.47% | +44.91% |
04-02 | ADMA Biologics, Inc. Announces Promotion of Kaitlin Kestenberg as Chief Operating Officer | CI |
03-26 | HC Wainwright Adjusts ADMA Biologics Price Target to $7.50 From $6, Maintains Buy Rating | MT |
Sales 2024 * | 334M 456M | Sales 2025 * | 390M 533M | Capitalization | 1.52B 2.07B |
---|---|---|---|---|---|
Net income 2024 * | 67M 91.5M | Net income 2025 * | 114M 156M | EV / Sales 2024 * | 4.55 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.89 x |
P/E ratio 2024 * |
22.2
x | P/E ratio 2025 * |
13.1
x | Employees | 624 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.47% |
Latest transcript on ADMA Biologics, Inc.
1 day | +1.71% | ||
1 week | +4.47% | ||
Current month | -0.76% | ||
1 month | -2.82% | ||
3 months | +28.68% | ||
6 months | +97.89% | ||
Current year | +44.91% |
Managers | Title | Age | Since |
---|---|---|---|
Adam Grossman
CEO | Chief Executive Officer | 47 | 06-06-01 |
Compliance Officer | 37 | 10-12-31 | |
Skyler Bloom
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Lawrence Guiheen
BRD | Director/Board Member | 73 | 12-07-23 |
Bryant Fong
BRD | Director/Board Member | 51 | 12-04-30 |
Steven Elms
CHM | Chairman | 60 | 06-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.01% | 9 M€ | +6.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 6.55 | +1.71% | 1,565,517 |
24-04-25 | 6.44 | -0.31% | 1,531,854 |
24-04-24 | 6.46 | -1.22% | 1,716,472 |
24-04-23 | 6.54 | +5.48% | 2,752,319 |
24-04-22 | 6.2 | -1.12% | 2,301,644 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.91% | 1.52B | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- ADMA Stock